A hydroquinone-specific screening system for directed P450 evolution

dc.bibliographicCitation.firstPage9657eng
dc.bibliographicCitation.issue22eng
dc.bibliographicCitation.journalTitleApplied microbiology and biotechnologyeng
dc.bibliographicCitation.lastPage9667eng
dc.bibliographicCitation.volume102eng
dc.contributor.authorWeingartner, Alexandra M.
dc.contributor.authorSauer, Daniel F.
dc.contributor.authorDhoke, Gaurao V.
dc.contributor.authorDavari, Mehdi D.
dc.contributor.authorRuff, Anna Joëlle
dc.contributor.authorSchwaneberg, Ulrich
dc.date.accessioned2022-02-22T10:50:28Z
dc.date.available2022-02-22T10:50:28Z
dc.date.issued2018
dc.description.abstractThe direct hydroxylation of benzene to hydroquinone (HQ) under mild reaction conditions is a challenging task for chemical catalysts. Cytochrome P450 (CYP) monooxygenases are known to catalyze the oxidation of a variety of aromatic compounds with atmospheric dioxygen. Protein engineering campaigns led to the identification of novel P450 variants, which yielded improvements in respect to activity, specificity, and stability. An effective screening strategy is crucial for the identification of improved enzymes with desired characteristics in large mutant libraries. Here, we report a first screening system designed for screening of P450 variants capable to produce hydroquinones. The hydroquinone quantification assay is based on the interaction of 4-nitrophenylacetonitrile (NpCN) with hydroquinones under alkaline conditions. In the 96-well plate format, a low detection limit (5 μM) and a broad linear detection range (5 to 250 μM) were obtained. The NpCN assay can be used for the quantification of dihydroxylated aromatic compounds such as hydroquinones, catechols, and benzoquinones. We chose the hydroxylation of pseudocumene by P450 BM3 as a target reaction and screened for improved trimethylhydroquinone (TMHQ) formation. The new P450 BM3 variant AW2 (R47Q, Y51F, I401M, A330P) was identified by screening a saturation mutagenesis library of amino acid position A330 with the NpCN assay. In summary, a 70-fold improved TMHQ formation was achieved with P450 BM3 AW2 when compared to the wild type (WT) and a 1.8-fold improved TMHQ formation compared to the recently reported P450 BM3 M3 (R47S, Y51W, A330F, I401M). © 2018, The Author(s).eng
dc.description.versionpublishedVersioneng
dc.identifier.urihttps://oa.tib.eu/renate/handle/123456789/8049
dc.identifier.urihttps://doi.org/10.34657/7090
dc.language.isoengeng
dc.publisherBerlin ; Heidelberg ; New York : Springereng
dc.relation.doihttps://doi.org/10.1007/s00253-018-9328-3
dc.relation.essn1432-0614
dc.rights.licenseCC BY 4.0 Unportedeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/eng
dc.subject.ddc570eng
dc.subject.otherAromatic hydroxylationeng
dc.subject.otherDirected evolutioneng
dc.subject.otherHydroquinoneeng
dc.subject.otherP450 BM3eng
dc.subject.otherProtein engineeringeng
dc.subject.otherScreening assayeng
dc.titleA hydroquinone-specific screening system for directed P450 evolutioneng
dc.typeArticleeng
dc.typeTexteng
tib.accessRightsopenAccesseng
wgl.contributorDWIeng
wgl.subjectBiowissensschaften/Biologieeng
wgl.typeZeitschriftenartikeleng
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Weingartner2018_Article_AHydroquinone-specificScreenin.pdf
Size:
2.28 MB
Format:
Adobe Portable Document Format
Description: